Lopez, Christopher E. http://orcid.org/0000-0001-5261-5347
Zacharias, Zeb R.
Ross, Kathleen A. http://orcid.org/0000-0003-2510-6779
Narasimhan, Balaji http://orcid.org/0000-0002-7955-5353
Waldschmidt, Thomas J.
Legge, Kevin L. http://orcid.org/0000-0001-9800-6854
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (AI127565, AI168001, AI141196, AI007533, AI007485, AI007533, AI007485, Ai127565, AI127565, AI141196)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 23 June 2023
Accepted: 7 May 2024
First Online: 31 May 2024
Competing interests
: K.L.L., T.J.W., and B.N. disclose they are co-founders of ImmunoNanoMed Inc., a start-up business with interests in the development of nano-based vaccines against infectious diseases. K.L.L., T.J.W., B.N., and K.A.R. are inventors on various patents related to nanovaccines.